Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
-

-

 
WKN: A12B8E / Symbol: HZNP / Name: Horizon Pharma / Stock / Pharmaceuticals / Mid Cap /
Latest predictions
24.10.23
0.00%
buy
13.09.23
2.79%
buy
16.07.23
20.92%
buy
08.07.23
18.20%
buy
29.05.23
16.95%
buy
21.05.23
19.87%
buy
Best running prediction
-
16.07.23
20.92%
buy
Your prediction

Horizon Pharma plc Stock

Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Horizon Pharma plc stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Horizon Pharma plc in the next few years

Pros
?
C******** o* t** e**********
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Horizon Pharma plc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Horizon Pharma plc - - - - - - -
Jazz Pharmaceuticals plc -5.590% 2.569% -6.989% -18.556% -6.948% -23.111% -11.282%
Catalent Inc. -0.170% 0.134% 0.038% 14.989% 26.990% -44.340% 52.359%
Opko Health Inc. 2.280% 1.027% 4.537% -12.665% -18.512% -65.907% -46.166%

Comments

Horizon Therapeutics Public Limited (NASDAQ: HZNP) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Ratings data for HZNP provided by MarketBeat
Show more

Horizon Therapeutics Public Limited (NASDAQ: HZNP) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for HZNP provided by MarketBeat
Show more

Horizon Therapeutics Public Limited (NASDAQ: HZNP) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for HZNP provided by MarketBeat
Show more